President Trump has indicated he may ease federal restrictions on marijuana, specifically by rescheduling cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). This would be the first move his...more
8/15/2025
/ Administrative Procedure Act ,
Cannabis-Related Businesses (CRBs) ,
Controlled Substances Act ,
DEA ,
Department of Justice (DOJ) ,
Food and Drug Administration (FDA) ,
Marijuana ,
Popular ,
Research and Development ,
Tax Deductions ,
Trump Administration
Even with the expected rescheduling of cannabis from a Schedule I drug to a Schedule III drug, it will take more for it to be eligible for interstate commerce.
Marijuana would remain subject to provisions of the Food,...more
6/27/2024
/ Cannabis Products ,
Controlled Substances Act ,
DEA ,
Department of Health and Human Services (HHS) ,
Dormant Commerce Clause ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Interstate Commerce ,
Marijuana Regulation & Taxation Act (MRTA) ,
Reclassification Rules ,
Schedule I Drugs
In a boon to the cannabis industry, the federal government is reclassifying cannabis and easing federal restrictions on the drug, according to news reports. The Drug Enforcement Administration will approve a recommendation...more